DexCom. has been granted a patent for a system that enables wireless communication between an analyte sensor and partner devices, such as insulin pumps. The system allows for configuration and data sharing, enhancing diabetes management by integrating analyte data and insulin dosage information for improved user support. GlobalData’s report on DexCom gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on DexCom, Medical data analysis was a key innovation area identified from patents. DexCom's grant share as of June 2024 was 45%. Grant share is based on the ratio of number of grants to total number of patents.
Wireless communication system for diabetes management devices
The patent US12047381B2 describes a system that integrates a display device with an analyte sensor application and a partner device, specifically an insulin pump, which operates through a communication interface. The system allows the display device to collect and display information from the insulin pump, including historical insulin dosage data and real-time analyte data. The analyte sensor application is designed to monitor the functionality of the analyte sensor system and provide alerts related to both the sensor and the insulin pump. Additionally, the display device can store and allow user interaction with both analyte-related and medicament-related data through a graphical user interface.
The system further enhances user experience by utilizing a continuous connection model for communication between the display device and the analyte sensor system. This model ensures that the display device remains connected by periodically exchanging messages, which includes receiving alerts about potential issues with the insulin pump. The system also supports remote monitoring by allowing the display device to transmit analyte and medicament delivery information to an electronic device used by a follower of the user, enabling them to receive alerts and monitor glucose and insulin data. Overall, the patent outlines a comprehensive approach to managing diabetes care through integrated technology, facilitating better monitoring and management of insulin delivery based on real-time glucose data.
To know more about GlobalData’s detailed insights on DexCom, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
